Webinars on demand

Clinical trials are increasingly using liquid biopsy samples to complement or as an alternative to invasive tissue sample collections.

Targeting of the programmed cell death protein (PD-1)/ programmed death-ligand 1 (PD-L1) axis with checkpoint inhibitors has changed clinical practice in non-small cell lung cancer (NSCLC).

During this webinar, we will demonstrate a novel in situ detection strategy to better characterize the inflammatory burden during kidney and cardiac allograft rejection by targeting NK cells, T lymphocytes and macrophages.

Indica Labs is proud to introduce our HALO AP, state-of-the-art anatomic pathology software.

The acquisition and interpretation of digital, whole slide images (WSI) of microscope slides for diagnosis has potential to transform pathology practice.

Join this webinar to find out how you can go digital right away at no cost.

Fusion based biomarkers are becoming more and more important in precision oncology clinical research.

The remarkable advances in precision medicine are unfortunately not currently available to all patients, especially those being treated in community cancer settings.

In this webinar, expert speakers from the Fred Hutchinson Cancer Research Center will discuss how they successfully implemented an automated, multiplexed tissue imaging platform for spatial profiling of the TME.

In this webinar, expert speakers from the Fred Hutchinson Cancer Research Center will discuss how they successfully implemented an automated, multiplexed tissue imaging platform for spatial profiling of the TME.

Whilst NGS has been instrumental to precision oncology research progress, practical hurdles have still been hindering its broad implementation…………Not anymore.

Whilst NGS has been instrumental to precision oncology research progress, practical hurdles have still been hindering its broad implementation…………Not anymore.